The LNCaP cell line. which xas derived from a lymph node metastasis of a patient who did not respond to endocrine therapy. is frequently used as a model for studying human prostate cancer (Horoszexxicz et al. 1983) . It is know-n that steroid and peptide hormones as well as differentiation-promoting substances regulate proliferative and secretorv responses in LNCaP cells. The cells respond to androgen stimulation by acceleratinc division and producing prostate-specific antigen (PSA) . The patterns of androaenic reaulation of growth and secretory function in the LNCaP cell line are different (Lee et al. 1995) . The maximal growth rate is achiexed at 0.1 nm of dihydrotestosterone (DHT). whereas higher doses of this androgen induce grow-th arrest. It w as proposed that the inhibition of cellular proliferation by high androgen doses is mediated by transforming growth factor j (TGF-P) (Kim et al. 1996) . In contrast to the proliferative response. the percentage of PSA-positix e cells and the levels of PSA protein in LNCaP supernatants increase at concentrations of 1 nmi dihydrotestosterone and bevond (Lee et al. 1995) . In addition to androgens. polypeptide growth factors such as epidermnal growth factor (EGF). TGF-at. insulin-like growth factors and basic fibroblast growth factor (bFGF) are mitonenic for LNCaP cells (Wildinn et al. 1989: MacDonald and Habib. 1992: Nakamoto et al. 1992: Ritchie et al. 1997) . Positix e effects of triiodothvronine and inhibitorx effects of xitamin D. retinoic acid. luteinizin5 hormone-releasing hormone. phenylacetate and actixin on grrow-th of LNCaP cells has-e also been described (Limonta et al. 1992 : Skoxxronski et al. 1993 : Young et al. 1994 : Esquenet et al. 1995 : Dalkin et al. 1996 : Walls et al. 1996 . Secretion of PSA ,A-as found to be enhanced after treatment with triiodothvronine. vitamin D and pheny lacetate (Skowronski et al. 1993 : Esquenet et al. 1995 : W'alls et al. 1996 . wxhereas divergent results on PSA regulation by retinoic acid wA-ere reported (Fona et al. 1993 : Youna et al. 1994 . LNCaP cells express a mutant androgen receptor (AR). wxhich binds oestrogenic and progestagenic steroids and non-steroidal anti-androgens hN-droxvflutamide and nilutamide with hiaher affinitv than the wild-type AR. These substances induce reporter gene actixitx in the presence of LNCaP AR more efficientlI than in the presence of the %vild-trpe AR (Veldscholte et al. 1990) .
Studies on interactions betw een leucocytes that produce X arious cvtokines and differentiation factors and prostate tumour cells max improve understandinc of prostate cancer biologx. In one of the initial studies in this field Hsieh et al (1995) have shoxxn that phytohaemagglutinin (PPHA )-stimulated lymphocvtes produce substance(s) that reduce cell prohiferation. increase expression of cytoskeleton proteins and down-regulate AR and PSA in LNCaP cells. These effects A-ere obserxed after treatment with xarious concentrations of T-lymphocyte-conditioned media (TCM1). Hoxx exer. the T-cell-derixved factor(s) that mediate these effects hax e so far not been identified. Interactions betxween other cells of the immune system and various tumours haxe been described (Wang et al. 1996 : Iversen et al. 1997 centrifugiation (3800g. 3 min) and w-ashed twice w-ith 500 gl of ice-cold medium. The cell pellets w-ere then lysed in 1 ml of scintillation liquid and the radioactix ity \-as determined in a P-counter.
Cellular protein w-as determined according to the method described by Bradford (1978 
RESULTS

Monocyte-conditioned medium-treated LNCaP cells show changes in cell shape
To study the influence of monocv-tes on prostate cancer cells. LNCaP cells w-ere exposed to medium conditioned by peripheral blood monocytes homogenously positive for CD14 (Firure 1A). Distinct morphological changes in LNCaP cells were observed after treatment with monocyte-conditioned medium (MCM). The cells became elongated and show ed dendrite-like processes. hich were connected to each other (Figure 2 ). These morphological changes were notable even Awith 10%7 MCM in LNCaP culture medium. Expression of cytoskeletal proteins w-as evaluated by semiquantitatixe immunohistochemistr-. A monoclonal antibodv directed against luminal cy-tokeratins 8 and 18 was used for this purpose. The expression and staining intensit-of these cvtokeratins 'Aere previously reported to increase in the more differentiated prostatic luminal epithelium Figure 5 ).
IL-1i is responsible for the modulatory effects of MCM
We focused on the contribution of individual factors to the MCM modulatory effects. Initially, we investigated the role of prostaglandin E2, which is a major product of activated monocytes (Venkataprasad et al, 1996) . LNCaP cells treated with prostaglandin E2 showed neither a reduction in proliferation nor a down-regulation of AR and PSA levels. Thus, prostaglandin E2 can be excluded as a mediator of the inhibitory effects of monocytes on androgen-responsive prostate cancer cells. Next, we examined the role of the proinflammatory cytokine IL-1p, which exhibits anti-tumour activity in several models (Kilian et al, 1991; Braunschweiger et al, 1996) , in the interaction between the immune system and prostate cancer cells. In order to determine whether IL-1 1 mediates MCM effects on LNCaP cells, MCM was preincubated with a neutralizing polyclonal anti-IL-l,B antibody. The effectiveness of this antibody was previously demonstrated in other assay systems (Salem et al, 1990; Lisak and Bealmear, 1991) . MCM pretreated with the antibody did not reduce LNCaP cell proliferation ( Figure 6A ). The MCM effect on AR protein was completely abolished after preincubation of MCM with the polyclonal anti-IL-15 antibody ( Figure 6B ), and the PSA levels were almost completely restored ( Figure 6C ). Moreover, addition of Figure 6A ). the AR protein lexvels decreased ( Figure 6D3 ) and PSA secretion xxas dirminished (Ficrure 6C(. Finally. LNCaP cells xxere shoxxn to express the IL-l13 receptor type I (Figure 1 B) . xx hich transduces IIL-113 sigrnal (Curtis et al. 1989 (Bang, et al. 1994 ). There was, however, one difference betxxeen MCM-and TCM-treated LNCaP cells. The expression of cy-tokeratins 8 and 18 and their staining intensity increased twofold after incubation xxith TCM as determined by% a tota intensitV score procedure (Hsieh et al. 1995 (Noordzij et al. 1996) . In that publication and in our prexvious expenimental studies neuroendocrine cells within the LNCaP cell line were not identified (unpublished data). Thus (Yuan et al. 1993 al. 1990 : Culig, et al. 1993 . 1994 : Kokontis et al. 1994 : Nazareth and Weigel1. 1996 (Walls et al. 1996 : Zhao et al. 1997 Cancer (1998) 
